Glycans in Diseases and Therapeutics

Glycomedicine plays major role in cell-cell adhesion i.e. a method used by cells of the immune system via sugar-binding proteins called lectins, which identifies specific carbohydrate moieties. Glycan’s (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play major roles in many biological phenomena as well as in various pathophysiological processes. Many scientists in other fields of research have now realized that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is an important field of research and sometimes they require a glycobiology and/or glycochemistry approach to be used.

  • Cancer associated coagulopathies
  • Cancer biomarkers
  • Cardiac arrest
  • Cardiovascular diseases
  • Congenital disorders of glycosylation (CDG)
  • Glycomedicine
  • Transfusion medicine

Related Conference of Glycans in Diseases and Therapeutics

September 21-22, 2026

24th International Conference on Structural Biology

Barcelona, Spain
May 24-25, 2027

23rd World Congress on Structural Biology

Paris, France

Glycans in Diseases and Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in